Tesamorelin is a stable of growth-hormone axis research. This page covers what it is, the research areas it appears in, and how to source it with proper documentation from Australian stock.
What is Tesamorelin?
Tesamorelin is a stabilised analogue of growth-hormone-releasing hormone (GHRH) that acts on the GHRH receptor. It is well referenced in endocrine research.
The parent hormone it copies is a 44-amino-acid peptide the body produces to signal the pituitary. Its weakness as a research tool is speed of breakdown — native GHRH is cleared within minutes by the enzyme dipeptidyl peptidase-4, which cuts it at a specific point near one end of the chain. Tesamorelin is that sequence with a trans-3-hexenoic acid group attached to the N-terminus, and the addition sits precisely where the enzyme would otherwise cut. Blocking that site is the whole design.
The result is the same signal with a considerably longer working life. That distinction — a stabilised copy of an endogenous hormone rather than a novel molecule — is what makes it a reference compound in GHRH-receptor work: researchers get the natural signalling pathway without the inconveniently short half-life.
Where Tesamorelin sits among growth-hormone research compounds
The growth-hormone axis has two separate entry points, and compounds in this category act on one or the other:
- The GHRH receptor — the body's own "release" instruction. Tesamorelin and CJC-1295 act here.
- The ghrelin receptor (GHS-R) — a second, independent pathway. Ipamorelin acts here.
Because these are genuinely different receptors on different pathways, they're frequently studied together rather than as alternatives — which is the reasoning behind combination preparations like the CJC-1295 / Ipamorelin blend. Tesamorelin's distinguishing feature within the GHRH group is that it is a stabilised copy of the natural 44-amino-acid sequence, rather than a shortened fragment.
Research areas
In the scientific literature, Tesamorelin is studied in relation to:
- Growth-hormone axis research
- GHRH-receptor signalling research
- Visceral-fat and body-composition research
- Endocrine and pituitary-signalling research
- Enzymatic-stability and peptide-design research
These describe fields of scientific study — they are not claims about effects in humans. Nothing here should be read as a statement about what the compound does in a person; NextGen Peptides supplies it strictly for laboratory and in-vitro research use.
The last item on that list is worth noting, because Tesamorelin is often cited as a worked example of a general principle in peptide chemistry: identify where an enzyme cleaves a natural hormone, block that specific site, and you extend the molecule's working life without altering what it signals. That approach recurs across the whole field, and this compound is one of the cleaner demonstrations of it.
Storage & handling
Supplied as a lyophilised (freeze-dried) powder. Store at −20°C; reconstitute with bacteriostatic water and refrigerate. See our full guide to storing and reconstituting research peptides, and what to mix it with in our bacteriostatic water guide.
At 44 amino acids this is one of the longer chains in the range, and longer peptides are generally less forgiving of rough handling than short ones — there is simply more structure to lose. Reconstitute by running the diluent slowly down the inside wall of the vial and swirling until dissolved; never shake, and treat foaming as a warning sign. Refrigerate at 2–8°C once mixed, keep vials boxed and out of light, and never refreeze a reconstituted solution. Concentration is set by the diluent volume you choose — our reconstitution calculator handles the arithmetic.
Sourcing Tesamorelin in Australia
We hold Tesamorelin in Australian stock, so orders placed before the daily cut-off are dispatched same or next business day — no overseas freight, no customs wait. Every batch is independently third-party tested, with the Certificate of Analysis published. New to buying research peptides? Read our Australian buyer’s guide first.
Common questions about Tesamorelin
What is Tesamorelin?
A stabilised analogue of growth-hormone-releasing hormone (GHRH) that acts on the GHRH receptor, referenced in endocrine research. Supplied for laboratory research use only.
What research areas is Tesamorelin studied in?
Growth-hormone axis research, GHRH-receptor signalling, and visceral-fat and body-composition research. These are fields of study, not effects in humans.
Is Tesamorelin tested and does it come with a CoA?
Yes. Every batch is independently tested for purity (RP-HPLC) and identity (LC-MS), with the Certificate of Analysis published in our CoA Library.
Is Tesamorelin held in Australian stock?
Yes. We hold Tesamorelin in Australian stock and dispatch same or next business day for orders placed before the daily cut-off.
What makes Tesamorelin "stabilised"?
A trans-3-hexenoic acid group attached to the N-terminus, positioned exactly where the enzyme dipeptidyl peptidase-4 would otherwise cleave the chain. Blocking that site extends the molecule's working life without changing what it signals.
How is Tesamorelin different from Ipamorelin?
Different receptors entirely. Tesamorelin acts on the GHRH receptor — the body's own release instruction. Ipamorelin acts on the ghrelin receptor, a separate pathway. They're studied together rather than as substitutes.
How is it different from CJC-1295?
Both act on the GHRH receptor. Tesamorelin is a stabilised copy of the full 44-amino-acid natural sequence; CJC-1295 is based on a shortened fragment. See the full comparison.
How long does a reconstituted vial last?
Generally around four weeks refrigerated at 2–8°C when reconstituted with bacteriostatic water. Unreconstituted powder at −20°C keeps far longer. Never refreeze a reconstituted solution.
Does it need cold-chain shipping?
No. Lyophilised powder is stable in transit. Orders ship from Melbourne in discreet, unmarked packaging with tracking — see shipping & delivery.
Legal status and intended use
Tesamorelin is supplied by NextGen Peptides strictly as a research chemical for laboratory and in-vitro use. It is not an approved therapeutic good in Australia, it is not supplied for human or veterinary consumption, and nothing on this site constitutes medical advice. Purchasers must be 18 or over. For the regulatory framework, see our guide to the legal status of research peptides in Australia.
Quick facts
SKU: TES-20 · 20MG per vial · Batch-tested with published CoA · Held in Australian stock · Same or next business day dispatch · For laboratory research use only.
Related research
Explore related compounds held in Australian stock: Ipamorelin and CJC-1295 / Ipamorelin.
Further reading: Tesamorelin vs CJC-1295.
Supplied strictly for laboratory and in-vitro research use only. Not for human or veterinary consumption. The research areas listed describe fields of scientific study, not claims about effects in humans, and nothing here is medical advice.